Skip to main content

how does Tirzepatide work for weight loss?

 Tirzepatide is a medication that is FDA-approved for the treatment of type 2 diabetes. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide

1
. It is taken as a weekly injection to help balance blood sugar in combination with a reduced-calorie diet and increased physical activity. During clinical trials, participants lost up to 20% of their starting weight
2
. As a result, some healthcare professionals prescribe tirzepatide off-label for weight loss, although the FDA has not yet approved it for this use
2
.

How does Tirzepatide work?

Tirzepatide works as both a GLP-1 and a GIP receptor agonist, rather than being one or the other. This gives it a unique edge over other similar treatments
3
. Tirzepatide affects GIP and GLP-1 hormones, which slows digestion and helps you feel full while lowering blood sugar
3
.

Research on Tirzepatide for weight loss

Several studies have been conducted on the efficacy and safety of tirzepatide for weight loss. A systematic review and meta-analysis of all currently available randomized controlled trials (RCTs) of tirzepatide in individuals with T2DM and obesity showed a significant reduction in body weight in the tirzepatide group versus the placebo group by -9.81 kg
4
. Another study showed that tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes
5
.

Side effects of Tirzepatide

The most common side effects of tirzepatide are temporary and include nausea, diarrhea, and stomach pain. A decreased appetite is also typical. More serious side effects, such as gallbladder problems and pancreatitis, are rare but possible
6
7
. Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional
7
.

Contraindications of Tirzepatide

Tirzepatide is contraindicated in patients with a previous serious hypersensitivity reaction to tirzepatide or any of the excipients in MOUNJARO, personal or family history of medullary thyroid carcinoma, or in patients with multiple endocrine neoplasia syndrome type 2. It is also contraindicated in patients with known serious hypersensitivity to tirzepatide or any of the excipients in MOUNJARO
8
9
10
.It is important to note that appropriate studies have not been performed on the relationship of age to the effects of tirzepatide injection in the pediatric population. Safety and efficacy have not been established. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of tirzepatide injection in the elderly. However, elderly patients are more sensitive to the effects of this medicine than younger adults
11
.If you are considering tirzepatide for weight loss, it is important to discuss the potential benefits and risks with your healthcare provider.
Labels:
Location: München, Deutschland

Comments

Post a Comment

Popular posts from this blog

Flying Just Got a Lot More Expensive — and Tariffs Are Only the Beginning

 As trade tensions escalate between major economies, new tariff uncertainties are weighing heavily on airlines. The consequences will ripple far beyond boardrooms and airfields: travelers should expect higher ticket prices, fewer route options, and a possible reshaping of the global aviation landscape. Immediate Impacts: Airlines Navigate a New Set of Risks In the short term, airlines are grappling with a complex mix of operational challenges: First, the aircraft supply chain is under pressure. Trade disputes between the United States, the European Union, and China have complicated the procurement of new planes. Manufacturers like Boeing, Airbus, and China's state-backed COMAC are caught in the middle, creating delays and pricing uncertainty for carriers ( Reuters ). Fuel markets are similarly volatile. Airlines typically hedge fuel prices months in advance to avoid sudden cost spikes. However, unpredictable shifts in global oil prices—driven in part by trade instability—are u...
Post a Comment
Read more

What’s it like to grow up in Vienna, Austria? | Young and European

Key Themes and Insights: City Overview 🏙️ Vienna is often referred to as the 'City of Music' and has consistently been voted the world's most livable city. ✨ The city balances open-mindedness with rich traditions, offering impressive infrastructure and educational opportunities. Living Environment 🏡 Sebi enjoys living in the eighth district, Josefstadt, known for its proximity to the city center but high rental prices. 💰 The average rent in Vienna is €9.80 per square meter, making it relatively affordable compared to other European cities, although this district is an exception. Education System 📚 Sebi attends one of the oldest schools in Vienna, where he studies multiple languages and engages in higher education preparation. 🎓 The average age for Austrians to move out is 25.5 years, with many students like Sebi aspiring to continue their education at nearby universities, such as the University of Vienna. Transportation 🚉 Vienna has an excellent public transport syste...
Post a Comment
Read more

Why U.S. Tech Giants Are Betting Big on Canadian AI?

  Why U.S. Tech Giants Are Betting Big on Canadian AI Imagine this: the most powerful tech companies in the world—Google, Meta, Microsoft—are betting their futures not just in Silicon Valley, but thousands of miles north, in the snowy cities of Canada. Strange, right? Why would billion-dollar U.S. tech giants rely so heavily on Canadian AI labs? What do Canadian researchers have that the tech capitals of California don’t? And could this quiet dependence shift the global tech balance? Let’s dive into a story of brainpower, policy, and a silent AI revolution that began long before most of us even knew what AI was. The Roots of Canada's AI Advantage To understand why U.S. tech titans are now so deeply entwined with Canada’s AI ecosystem, we need to go back to the early days of AI research—in the 1980s and '90s. At that time, the initial hype around artificial intelligence had faded. Funding was drying up globally, and many dismissed AI, especially deep learning, as a dead en...
Post a Comment
Read more